Ganglionic blocking properties of 3-methylaminoisocamphane hydrochloride (mecamylamine): a secondary amine.

作者信息

STONE C A, TORCHIANA M L, NAVARRO A, BEYER K H

出版信息

J Pharmacol Exp Ther. 1956 Jun;117(2):169-83.

PMID:13332559

Abstract

摘要

相似文献

Ganglionic blocking properties of 3-methylaminoisocamphane hydrochloride (mecamylamine): a secondary amine.

J Pharmacol Exp Ther. 1956 Jun;117(2):169-83.

Renal elimination of 3-methylaminoisocamphane hydrochloride (mecamylamine).

Am J Physiol. 1956 Jul;186(1):180-6. doi: 10.1152/ajplegacy.1956.186.1.180.

Drug therapy of hypertension. II. Experience with reserpine, apresoline, ansolysen, ecolid, and mecamylamine (inversine).

N Y State J Med. 1956 Aug 15;56(16):2487-97.

Drug therapy (mecamylamine) of hypertension. III. Results with mecamylamine, a completely absorbed ganglionic blocking agent.

AMA Arch Intern Med. 1956 Aug;98(2):187-210.

Gastrointestinal secretion and absorption of 3-methylaminoisocamphane hydrochloride (mecamylamine).

J Pharmacol Exp Ther. 1958 Apr;122(4):442-8.

[Experimental & clinical observation on the activity of a new synthetic ganglioplegic: mecamylamine (3-methylaminoisocamphane hydrochloride)].

Minerva Med. 1958 Feb 21;49(15):606-14.

[Mecamylamine; a new ganglion-blocking agent for management of hypertension].

Sven Lakartidn. 1956 Nov 2;53(44):2880-3.

[Influence of the effect of certain ganglion-blocking agents by gamma-methyl amide of camphoric acid].

Cesk Fysiol. 1960 May;9:286-7.

MECAMYLAMINE hydrochloride.

J Am Med Assoc. 1956 Dec 15;162(16):1469-71.

Investigation of the mechanism of the hemodynamic effects of ganglionic blockade produced by mecamylamine.

Am Heart J. 1960 Nov;60:777-84. doi: 10.1016/0002-8703(60)90360-4.

引用本文的文献

Acetylcholine and cholinergic receptors.

Brain Neurosci Adv. 2019 Mar 21;3:2398212818820506. doi: 10.1177/2398212818820506. eCollection 2019 Jan-Dec.

Discriminative stimulus effects of mecamylamine and nicotine in rhesus monkeys: Central and peripheral mechanisms.

Pharmacol Biochem Behav. 2019 Apr;179:27-33. doi: 10.1016/j.pbb.2019.02.002. Epub 2019 Feb 6.

An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamine.

Br J Clin Pharmacol. 2017 Aug;83(8):1676-1687. doi: 10.1111/bcp.13268. Epub 2017 Apr 8.

Nicotine inhibits potassium currents in Aplysia bag cell neurons.

J Neurophysiol. 2016 Jun 1;115(5):2635-48. doi: 10.1152/jn.00816.2015. Epub 2016 Feb 10.

The discriminative stimulus effects of mecamylamine in nicotine-treated and untreated rhesus monkeys.

Behav Pharmacol. 2014 Aug;25(4):296-305. doi: 10.1097/FBP.0000000000000054.

Diabetic macular edema: New promising therapies.

World J Diabetes. 2013 Dec 15;4(6):324-38. doi: 10.4239/wjd.v4.i6.324.

Potential therapeutic uses of mecamylamine and its stereoisomers.

Pharmacol Biochem Behav. 2013 Jul;108:28-43. doi: 10.1016/j.pbb.2013.04.005. Epub 2013 Apr 18.

Patterns of nicotinic receptor antagonism: nicotine discrimination studies.

J Pharmacol Exp Ther. 2011 Oct;339(1):194-202. doi: 10.1124/jpet.111.182170. Epub 2011 Jul 5.

Pempidine for Hypertension.

Br Med J. 1961 Jan 7;1(5218):13-5. doi: 10.1136/bmj.1.5218.13.

Topical mecamylamine for diabetic macular edema.

Am J Ophthalmol. 2010 May;149(5):839-51.e1. doi: 10.1016/j.ajo.2009.12.005. Epub 2010 Feb 26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验